A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Status:
Completed

Trial end date:
2019-05-22

Target enrollment:

Participant gender:

This study is conducted to evaluate the safety of a single intravitreal injection of THR-149.

Phase 1

ThromboGenics